中天宏信(00994.HK)成立合营从事电商零售及线上线下谘询服务
中天宏信(00994.HK)公布,与浙江顺联及浙江顺联的一名高级管理人员成立合营企业,主要从事自家品牌商品的电商零售业务,及为电商公司提供线上线下谘询服务业务。合营企业由公司全资附属公司深圳中天宏信、浙江顺联及浙江顺联的一名高级管理人员分别拥有51%、39%及10%。因此,合营企业为公司的附属公司。
公司指,成立合营企业是为善用中国电商行业的巨大潜力及浙江顺联在中国的声誉,以向电商公司提供采购服务及相关线上及线下谘询服务。
目前,合营企业已与中和亚健康服务中心订立战略合作协议,建立网上平台以销售保健产品及提供与保健有关的培训计划。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.